Summary & Overview
CPT 0945T: Intraoperative Fluorescence Imaging During Partial Mastectomy
CPT code 0945T indicates an intraoperative, add-on service in which computer-aided fluorescence imaging is used during a partial mastectomy to detect residual tumor tissue. As an adjunct to surgical excision, this technology can inform immediate resection decisions and potentially reduce the need for reoperation. Nationally, the code represents a targeted surgical imaging procedure relevant to breast-conserving surgery and related quality-of-care considerations.
Key payers included in this coverage discussion are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise national perspective on what the code represents, payer coverage context, and the clinical setting in which the service is provided.
This publication outlines the clinical purpose of the code, typical sites of service, and which major payers are considered in coverage discussions. It also highlights the types of benchmarks and policy updates readers can expect: utilization patterns for intraoperative imaging add-on services, common billing practices for add-on surgical imaging, and payer-specific coverage language or coding guidance where available. Clinical context clarifies how the imaging is used during partial mastectomy procedures and why the service may affect surgical decision-making. Data not available in the input will be noted explicitly where applicable.
Billing Code Overview
CPT code 0945T describes an add-on intraoperative imaging service performed during a partial mastectomy. The provider uses computer-aided fluorescence imaging at the surgical site to assess for any remaining abnormal (tumor) tissue, helping ensure removal of residual tumor during the procedure.
-
Service type: Intraoperative adjunctive imaging service (add-on to a partial mastectomy)
-
Typical site of service: Operative/surgical setting (inpatient or outpatient operating room or ambulatory surgical center)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a woman diagnosed with early-stage invasive breast carcinoma or ductal carcinoma in situ (DCIS) presenting for a breast-conserving surgery (partial mastectomy/lumpectomy). Preoperative workup includes imaging (mammography, ultrasound, often MRI) and core needle biopsy confirming malignancy. Intraoperatively, after excision of the targeted lesion with appropriate margins, the surgeon requests the add-on computer-aided fluorescence imaging service to assess the surgical bed for residual tumor tissue. The imaging system uses a fluorescent agent and real-time computer-assisted analysis to highlight areas of abnormal uptake that may represent residual tumor. If residual tissue is identified, the surgeon performs additional targeted excision to achieve clear margins. Typical workflow: preoperative planning and informed consent for partial mastectomy with possible intraoperative imaging; induction of anesthesia; partial mastectomy performed; application of fluorescence agent (if not pre-injected) and activation of imaging; interpretation of imaging results by the operating surgeon; additional resection as indicated; specimen sent to pathology for margin assessment. Typical site of service: hospital operating room or ambulatory surgical center during a partial mastectomy procedure.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When work required is substantially greater than typical for partial mastectomy with add-on imaging (document increased complexity). |